Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome

Yan, Yiqing, Jiang, Wei, Liu, Lei, Wang, Xiaqiong, Ding, Chen, Tian, Zhigang, Zhou, Rongbin·2015·Cell

Cited by (1,000)

Items 101–200 of 1,000

  1. Inflammatory pathways in Alzheimer’s disease mediated by gut microbiota
    Qian, Xiao-hang, Song, Xiao-xuan, Liu, Xiao-li, Chen, Sheng-di, Tang, Hui-dong · 2021 · Ageing Research Reviews
  2. ABRO1 promotes NLRP3 inflammasome activation through regulation of NLRP3 deubiquitination
    Guangming Ren, Xuanyi Zhang, Yang Xiao, Wen Zhang, Yu Wang, Wenbing Ma, Xiaohan Wang, Pan Song, Lili Lai, Hui Chen et al. · 2019 · The EMBO Journal
  3. Ligand recognition and allosteric regulation of DRD1-Gs signaling complexes
    Peng Xiao, Wei Yan, Lu Gou, Ya-Ni Zhong, Liangliang Kong, Chao Wu, Xin Wen, Yuan Yuan, Sheng Cao, Changxiu Qu et al. · 2021 · Cell
  4. Strategies for Targeting the NLRP3 Inflammasome in the Clinical and Preclinical Space
    Adam G. Schwaid, Kerrie B. Spencer · 2020 · Journal of Medicinal Chemistry
  5. Inflammasomes, the eye and anti-inflammasome therapy
    Praveen Yerramothu, Ajay Kumar Vijay, Mark D. P. Willcox · 2017 · Eye
  6. The physiology of foamy phagocytes in multiple sclerosis
    Elien Grajchen, Jerome J. A. Hendriks, Jeroen F. J. Bogie · 2018 · Acta Neuropathologica Communications
  7. Oxidative Stress and Neuroinflammation Potentiate Each Other to Promote Progression of Dopamine Neurodegeneration
    Jingyi He, Guofu Zhu, Guoqing Wang, Feng Zhang · 2020 · Oxidative Medicine and Cellular Longevity
  8. Structural basis for the oligomerization-mediated regulation of NLRP3 inflammasome activation
    Umeharu Ohto, Yukie Kamitsukasa, Hanako Ishida, Zhikuan Zhang, Karin Murakami, Chie Hirama, Sakiko Maekawa, Toshiyuki Shimizu · 2022 · Proceedings of the National Academy of Sciences
  9. The Role of the Inflammasome in Neurodegenerative Diseases
    Piancone, Federica, La Rosa, Francesca, Marventano, Ivana, Saresella, Marina, Clerici, Mario · 2021 · Molecules
  10. Vitamin B6 Prevents IL-1β Protein Production by Inhibiting NLRP3 Inflammasome Activation
    Peipei Zhang, K. Tsuchiya, Takeshi Kinoshita, Hiroko Kushiyama, Sofya Suidasari, Mizuki Hatakeyama, Hisanori Imura, Norihisa Katô, Takashi Suda · 2016 · Journal of Biological Chemistry
  11. The immune system in Parkinson's disease: what we know so far
    Cintia Roodveldt, Liliana Inácio Bernardino, Özgür Öztop Çakmak, Milorad Dragić, Kari Espolin Fladmark, Sibel Ertan, Büşra Aktaş, Carlos Pita, Lucia Ciglar, Gaëtan Garraux et al. · 2024 · Brain
  12. The Signaling Pathways Regulating NLRP3 Inflammasome Activation
    Chen, Ming-ye, Ye, Xun-jia, He, Xian-hui, Ouyang, Dong-yun · 2021 · Inflammation
  13. The neuroprotection of Sinomenine against ischemic stroke in mice by suppressing NLRP3 inflammasome via AMPK signaling
    Jing Qiu, Min Wang, Jun Zhang, Qing Cai, Dan Lu, Yansong Li, Yushu Dong, Tianzhi Zhao, Dawei Chen · 2016 · International Immunopharmacology
  14. TLR4 absence reduces neuroinflammation and inflammasome activation in Parkinson’s diseases in vivo model
    Michela Campolo, Irene Paterniti, Rosalba Siracusa, Alessia Filippone, Emanuela Esposito, Salvatore Cuzzocrea · 2018 · Brain Behavior and Immunity
  15. Control of the inflammasome by the ubiquitin system
    Gloria López‐Castejón · 2019 · FEBS Journal
  16. NLRP3 inflammasome: a key player in the pathogenesis of life-style disorders
    Rajath Ramachandran, Abdul Manan, Jei Kim, Sangdun Choi · 2024 · Experimental & Molecular Medicine
  17. Autophagy in neurodegeneration: New insights underpinning therapy for neurological diseases
    Corti, Olga, Blomgren, Klas, Poletti, Angelo, Beart, Philip M. · 2020 · Journal of Neurochemistry
  18. USP5 attenuates NLRP3 inflammasome activation by promoting autophagic degradation of NLRP3
    Baoshan Cai, Jian Zhao, Yuling Zhang, Yaxing Liu, Chunhong Ma, Fan Yi, Yi Zheng, Lei Zhang, Tian Chen, Huiqing Liu et al. · 2021 · Autophagy
  19. ARIH2 Ubiquitinates NLRP3 and Negatively Regulates NLRP3 Inflammasome Activation in Macrophages
    Akira Kawashima, Tadayoshi Karasawa, Kenji Tago, Hiroaki J. Kimura, Ryo Kamata, Fumitake Usui‐Kawanishi, Sachiko Watanabe, Satoshi Ohta, Megumi Funakoshi‐Tago, Ken Yanagisawa et al. · 2017 · The Journal of Immunology
  20. cAMP metabolism controls caspase-11 inflammasome activation and pyroptosis in sepsis
    Ruochan Chen, Ling Zeng, Shan Zhu, Jiao Liu, Herbert J. Zeh, Guido Kroemer, Haichao Wang, Timothy R. Billiar, Jianxin Jiang, Daolin Tang et al. · 2019 · Science Advances
  21. Dopamine-modified chitosan hydrogel for spinal cord injury
    Kun Liu, Xianzhen Dong, Yue Wang, Xiaopei Wu, Honglian Dai · 2022 · Carbohydrate Polymers
  22. The extended autonomic system, dyshomeostasis, and COVID-19
    David S. Goldstein · 2020 · Clinical Autonomic Research
  23. Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia
    Zheng Fan, Zhigang Liang, Hui Min Yang, Yuting Pan, Yan Zheng, Xiaomin Wang · 2017 · Journal of Neuroinflammation
  24. Inflammasome biology, molecular pathology and therapeutic implications
    Fawaz Awad, Eman Assrawi, Camille Louvrier, Claire Jumeau, Sophie Georgin‐Lavialle, Gilles Grateau, Serge Amselem, Irina Giurgea, Sonia‐Athina Karabina · 2018 · Pharmacology & Therapeutics
  25. Mitochondria at the interface between neurodegeneration and neuroinflammation
    Verian Bader, Konstanze F. Winklhofer · 2019 · Seminars in Cell and Developmental Biology
  26. Acetate attenuates inflammasome activation through GPR43-mediated Ca2+-dependent NLRP3 ubiquitination
    Mengda Xu, Zhengyu Jiang, Changli Wang, Na Li, Lulong Bo, Yanping Zha, Jinjun Bian, Yan Zhang, Xiaoming Deng · 2019 · Experimental & Molecular Medicine
  27. Dopaminergic Regulation of Innate Immunity: a Review
    Monica Pinoli, Franca Marino, Marco Cosentino · 2017 · Journal of Neuroimmune Pharmacology
  28. Curiosity in old age: A possible key to achieving adaptive aging
    Michiko Sakaki, Ayano Yagi, Kou Murayama · 2018 · Neuroscience & Biobehavioral Reviews
  29. Soluble α-synuclein–antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia
    Dorit Trudler, Kristopher L. Nazor, Yvonne S. Eisele, Titas Grabauskas, Nima Dolatabadi, James Parker, Abdullah Sultan, Zhenyu Zhong, Marshall S. Goodwin, Yona Levites et al. · 2021 · Proceedings of the National Academy of Sciences
  30. The Membrane-Associated MARCH E3 Ligase Family: Emerging Roles in Immune Regulation
    Heng Lin, Shu Li, Hong‐Bing Shu · 2019 · Frontiers in Immunology
  31. Neuro-immune crosstalk in cancer: mechanisms and therapeutic implications
    Tianyi Pu, Jiazheng Sun, Guosheng Ren, Hongzhong Li · 2025 · Signal Transduction and Targeted Therapy
  32. UAF1 deubiquitinase complexes facilitate NLRP3 inflammasome activation by promoting NLRP3 expression
    Hui Song, Chunyuan Zhao, Zhongxia Yu, Qizhao Li, Rongzhen Yan, Ying Qin, Mutian Jia, Wei Zhao · 2020 · Nature Communications
  33. α‐Synuclein evokes NLRP3 inflammasome‐mediated IL ‐1β secretion from primary human microglia
    Adrianne F. Pike, Tatiana Varanita, Maaike A. C. Herrebout, Bonnie C. Plug, Jeroen Kole, René J.P. Musters, Charlotte Elisabeth Teunissen, Jeroen J.M. Hoozemans, Luigi Bubacco, Robert Veerhuis · 2021 · Glia
  34. Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
    Michael J. Lucido, Mandakh Bekhbat, David R. Goldsmith, Michael Tilghman Treadway, Ebrahim Haroon, Jennifer C. Felger, Andrew H. Miller · 2021 · Pharmacological Reviews
  35. Principles of inflammasome priming and inhibition: implications for psychiatric disorders
    Herman, Francis J., Pasinetti, Giulio Maria · 2018 · Brain, Behavior, and Immunity
  36. Deubiquitination of NLRP6 inflammasome by Cyld critically regulates intestinal inflammation
    Sandip Kumar Mukherjee, Ritesh Kumar, Elviche L. Tsakem, Venkatesha Basrur, Dimitris L. Kontoyiannis, Fotis Ioakeimidis, George Mosialos, Arianne L. Theiss, Richard Anthony Flavell, K. Venuprasad · 2020 · Nature Immunology
  37. Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
    Adrianne F. Pike, Francesca Longhena, Gaia Faustini, Jean-Marc van Eik, Iris Gombert, Maaike A. C. Herrebout, Mona M.H.E Fayed, Michele Sandre, Tatiana Varanita, Charlotte Elisabeth Teunissen et al. · 2022 · Journal of Neuroinflammation
  38. MCC950, a Selective Inhibitor of NLRP3 Inflammasome, Reduces the Inflammatory Response and Improves Neurological Outcomes in Mice Model of Spinal Cord Injury
    Jianhang Jiao, Guanjie Zhao, Yang Wang, Pengfei Ren, Minfei Wu · 2020 · Frontiers in Molecular Biosciences
  39. NLRP3 phosphorylation in its LRR domain critically regulates inflammasome assembly
    Tingting Niu, Charlotte de Rosny, Séverine Chautard, Amaury Rey, Danish Patoli, Marine Groslambert, Camille Cosson, Brice Lagrange, Zhirong Zhang, Orane Visvikis et al. · 2021 · Nature Communications
  40. Arrestin-biased AT1R agonism induces acute catecholamine secretion through TRPC3 coupling
    Chun-Hua Liu, Zheng Gong, Zong-Lai Liang, Zhi-Xin Liu, Fan Yang, Yujing Sun, Ming-Liang Ma, Yi-Jing Wang, Chao-Ran Ji, Yu-Hong Wang et al. · 2017 · Nature Communications
  41. Targeting NLRP3 Inflammasome Activation in Severe Asthma
    Efthymia Theofani, Maria Semitekolou, Ioannis Morianos, Κonstantinos Samitas, Georgina Xanthou · 2019 · Journal of Clinical Medicine
  42. Bridging autism spectrum disorders and schizophrenia through inflammation and biomarkers – pre-clinical and clinical investigations
    Prata, Joana, Santos, Susana G., Almeida, Maria Inês, Coelho, Rui, Barbosa, Mário A. · 2017 · Journal of Neuroinflammation
  43. NLRP inflammasomes in health and disease
    Zhihao Xu, Arnaud John Kombe Kombe, Shasha Deng, Hongliang Zhang, Songquan Wu, Jianbin Ruan, Ying Yin Zhou, Tengchuan Jin · 2024 · Molecular Biomedicine
  44. Neuroimmune Communication in Health and Disease
    Colin Reardon, Kaitlin M. Murray, Alan E. Lomax · 2018 · Physiological Reviews
  45. Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease
    Qiu-Ling Chen, Haoran Yin, Qing‐Yu He, Ying Wang · 2021 · Biomedicine & Pharmacotherapy
  46. The Pathways Underlying the Multiple Roles of p62 in Inflammation and Cancer
    Paulina Hennig, Gabriele Fenini, Michela Di Filippo, Tugay Karakaya, Hans‐Dietmar Beer · 2021 · Biomedicines
  47. Loss-of-function CARD8 mutation causes NLRP3 inflammasome activation and Crohn’s disease
    Liming Mao, Atsushi Kitani, Morgan N. Similuk, Andrew J. Oler, Lindsey G. Albenberg, Judith R. Kelsen, Atiye Aktay, Martha Quezado, Michael D. Yao, Kim Montgomery-Recht et al. · 2018 · Journal of Clinical Investigation
  48. Vitamin D Receptor Inhibits NLRP3 Activation by Impeding Its BRCC3-Mediated Deubiquitination
    Zebing Rao, Xin Chen, Junxian Wu, Mengjun Xiao, Jing Zhang, Binghao Wang, Lei Fang, Hongjie Zhang, Xiaoming Wang, Shuo Yang et al. · 2019 · Frontiers in Immunology
  49. A novel PINK1- and PARK2-dependent protective neuroimmune pathway in lethal sepsis
    Rui Kang, Ling Zeng, Yangchun Xie, Zhengwen Yan, Bo Zhou, Lizhi Cao, Daniel J. Klionsky, Kevin J. Tracey, Jianhua Li, Haichao Wang et al. · 2016 · Autophagy
  50. Immunomodulatory Effects of Dopamine in Inflammatory Diseases
    Yifei Feng, Yan Lü · 2021 · Frontiers in Immunology
  51. Stressing out the mitochondria: Mechanistic insights into NLRP3 inflammasome activation
    Monica Yabal, Dale J. Calleja, Daniel S. Simpson, Kate E. Lawlor · 2018 · Journal of Leukocyte Biology
  52. Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages
    Ping Ke, Bo‐Zong Shao, Zhe‐Qi Xu, Wei Wei, Han Bin-Ze, Xiongwen Chen, Ding‐Feng Su, Chong Liu · 2016 · PLoS ONE
  53. Dopamine: an immune transmitter
    Sarah Thomas Broome, Krystal Louangaphay, Kevin A. Keay, Gian Marco Leggio, Giuseppe Musumeci, Alessandro Castorina · 2020 · Neural Regeneration Research
  54. Role of NLRP3 Inflammasome Activation in Obesity-Mediated Metabolic Disorders
    Kaiser Wani, Hind AlHarthi, Amani Ahmed Alghamdi, Shaun Sabico, Nasser M. Al‐Daghri · 2021 · International Journal of Environmental Research and Public Health
  55. Activation of dopamine D1 receptor decreased NLRP3-mediated inflammation in intracerebral hemorrhage mice
    Tian Wang, Derek Nowrangi, Lingyan Yu, Tai Lu, Jiping Tang, Bing Han, Yuxin Ding, Fenghua Fu, John H. Zhang · 2018 · Journal of Neuroinflammation
  56. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease
    Jialong Chen, Kanmin Mao, Honglin Yu, Yue Wen, Hua She, He Zhang, Linhua Liu, Mingque Li, Wenjun Li, Fei Zou · 2021 · Journal of Neuroinflammation
  57. Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease
    Emine Meltem Onal, Barış Afşar, Adrian Constantin Covic, Nosratola D. Vaziri, Mehmet Kanbay · 2018 · Hypertension Research
  58. Role of NLRP3 inflammasome-mediated neuronal pyroptosis and neuroinflammation in neurodegenerative diseases
    Ying‐Hao Han, Xiaodong Liu, Meihua Jin, Hu‐Nan Sun, Taeho Kwon · 2023 · Inflammation Research
  59. Recent Progress and Prospects of Small Molecules for NLRP3 Inflammasome Inhibition
    Na Li, Ruijia Zhang, Minghai Tang, Min Zhao, Xueqin Jiang, Xiaoying Cai, Neng Ye, Kaiyue Su, Jing Peng, Xinlu Zhang et al. · 2023 · Journal of Medicinal Chemistry
  60. Dopamine receptor D2 antagonism normalizes profibrotic macrophage-endothelial crosstalk in non-alcoholic steatohepatitis
    Jie Qing, Yafeng Ren, Yuwei Zhang, Mengli Yan, Hua Zhang, Dongbo Wu, Yongyuan Ma, Yutian Chen, Xiaojuan Huang, Qinkai Wu et al. · 2021 · Journal of Hepatology
  61. The cancer-immune dialogue in the context of stress
    Yuting Ma, Guido Kroemer · 2023 · Nature reviews. Immunology
  62. Increasing complexity of NLRP3 inflammasome regulation
    Julien Moretti, Julie Magarian Blander · 2020 · Journal of Leukocyte Biology
  63. How Mouse Macrophages Sense What Is Going On
    Klaus F. Ley, Akula Bala Pramod, Michael Croft, Kodi S. Ravichandran, Jenny P.‐Y. Ting · 2016 · Frontiers in Immunology
  64. The NLRP3 inflammasome - interleukin 1 pathway as a therapeutic target in gout
    Zoltán Szekanecz, Szilvia Szamosi, Gergő E. Kovács, Elek Kocsis, Szilvia Benkő · 2019 · Archives of Biochemistry and Biophysics
  65. Novel Role for Tranilast in Regulating NLRP3 Ubiquitination, Vascular Inflammation, and Atherosclerosis
    Suwen Chen, Yadong Wang, Ya‐mu Pan, Yao Liu, Shuang Zheng, Ke Ding, Kaiyu Mu, Ye Yuan, Zhaoyang Li, Hongxian Song et al. · 2020 · Journal of the American Heart Association
  66. Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies
    Mariacarmela Santarpía, Andrés Aguilar, Imane CHAIB-OUKADOUR, Andrés Felipe Cardona, Sara Fancelli, Fernando Laguía, Jillian Wilhelmina Paulina Bracht, Peng Cao, Miguel Ángel Molina‐Vila, Niki Karachaliou et al. · 2020 · Cancers
  67. Cryptotanshinone specifically suppresses NLRP3 inflammasome activation and protects against inflammasome-mediated diseases
    Hongbin Liu, Xiaoyan Zhan, Guang Xu, Zhilei Wang, Ruisheng Li, Yan Wang, Qin Qin, Wei Shi, Xiaorong Hou, Ruichuang Yang et al. · 2020 · Pharmacological Research
  68. Role of autophagy in the pathogenesis of multiple sclerosis
    Peizhou Liang, Weidong Le · 2015 · Neuroscience Bulletin
  69. NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
    Qiu-Qin Han, W. Le · 2023 · Neuroscience Bulletin
  70. PINK1/Parkin-Dependent Mitochondrial Surveillance: From Pleiotropy to Parkinson's Disease
    François Mouton‐Liger, Maxime Jacoupy, Jean‐Christophe Corvol, Olga Corti · 2017 · Frontiers in Molecular Neuroscience
  71. Inflammasomes and Proteostasis Novel Molecular Mechanisms Associated With Atrial Fibrillation
    Na Li, Bianca J.J.M. Brundel · 2020 · Circulation Research
  72. Dopamine Receptor-Mediated Binding and Cellular Uptake of Polydopamine-Coated Nanoparticles
    Yao Liu, Chun Kit K. Choi, Huiling Hong, Yu Xiao, Man Long Kwok, Hanzhuang Liu, Xiao Yu Tian, Chung Hang Jonathan Choi · 2021 · ACS Nano
  73. Immune responses in the Parkinson's disease brain
    Fiona C. Weiss, Adahir Labrador‐Garrido, Nicolas L. Dzamko, Glenda Margaret Halliday · 2022 · Neurobiology of Disease
  74. Interaction between integrin α5 and PDE4D regulates endothelial inflammatory signalling
    Yun, Sanguk, Budatha, Madhusudhan, Dahlman, James E., Coon, Brian G., Cameron, Ryan T., Langer, Robert, Anderson, Daniel G., Baillie, George, Schwartz, Martin A. · 2016 · Nature Cell Biology
  75. Zinc promotes functional recovery after spinal cord injury by activating Nrf2/HO-1 defense pathway and inhibiting inflammation of NLRP3 in nerve cells
    Daoyong Li, He Tian, Xian Li, Liang Mao, Xiaoguang Zhao, Jiaquan Lin, Sen Lin, Chang Xu, Yuanye Liu, Yue Guo et al. · 2020 · Life Sciences
  76. NLRP3 Ubiquitination—A New Approach to Target NLRP3 Inflammasome Activation
    Mahbuba Akther, Md. Ezazul Haque, Jooho Park, Tae‐Bong Kang, Kwang‐Ho Lee · 2021 · International Journal of Molecular Sciences
  77. Dopamine Uses the DRD5-ARRB2-PP2A Signaling Axis to Block the TRAF6-Mediated NF-κB Pathway and Suppress Systemic Inflammation
    Yuqing Wu, Yingchao Hu, Bingwei Wang, Sheng Li, Chunmei Ma, Xue Liu, Paul N. Moynagh, Jiawei Zhou, Shuo Yang · 2020 · Molecular Cell
  78. HUWE1 mediates inflammasome activation and promotes host defense against bacterial infection
    Yu Guo, Longjun Li, Tao Xu, Xiaomin Guo, Chaoming Wang, Yihui Li, Yanan Yang, Dong Yang, Bin Sun, Xudong Zhao et al. · 2020 · Journal of Clinical Investigation
  79. Rapamycin improves the neuroprotection effect of inhibition of NLRP3 inflammasome activation after TBI
    Yuhua Chen, Jiao Meng, Quanhua Xu, Tianlin Long, Fangfang Bi, Cuicui Chang, Wei Liu · 2019 · Brain Research
  80. Role of NLRP3 Inflammasome in Rheumatoid Arthritis
    Hui Yin, Na Liu, Keshav Raj Sigdel, Lihua Duan · 2022 · Frontiers in Immunology
  81. Inhibition of titanium-particle-induced inflammatory osteolysis after local administration of dopamine and suppression of osteoclastogenesis via D2-like receptor signaling pathway
    Huilin Yang, Yaozeng Xu, Mo Zhu, Ye Gu, Wen Zhang, Hongguo Shao, Yijun Wang, Zichuan Ping, Xuanyang Hu, Liangliang Wang et al. · 2015 · Biomaterials
  82. Regulation of inflammasomes by ubiquitination
    Joseph S. Bednash, Rama K. Mallampalli · 2016 · Cellular and Molecular Immunology
  83. Scutellarin Suppresses NLRP3 Inflammasome Activation in Macrophages and Protects Mice against Bacterial Sepsis
    Yi Fan Liu, Yan-Yun Jing, Chenying Zeng, Chenguang Li, Lihui Xu, Yan Liang, Wen-Jing Bai, Qingbing Zha, Dong‐Yun Ouyang, Xian‐Hui He · 2018 · Frontiers in Pharmacology
  84. Plin4-Dependent Lipid Droplets Hamper Neuronal Mitophagy in the MPTP/p-Induced Mouse Model of Parkinson’s Disease
    Han, Xiaojuan, Zhu, Jialei, Zhang, Xinlei, Song, Qiqi, Ding, Jianhua, Lu, Ming, Sun, Sifan, Hu, Gang · 2018 · Frontiers in Neuroscience
  85. Propionate and butyrate attenuate macrophage pyroptosis and osteoclastogenesis induced by CoCrMo alloy particles
    Yanglin Wu, Chenhui Zhang, Yun Teng, Ying Pan, Naicheng Liu, Pei-Xin Liu, Xu Hui Zhu, Xinlin Su, Jun Lin · 2022 · Military Medical Research
  86. The role of NLRP3 inflammasome in aging and age-related diseases
    Ruikai Liang, Xinrui Qi, Qi Cai, Liyan Niu, Xi Huang, Deju Zhang, Jitao Ling, Yuting Wu, Yixuan Chen, Pingping Yang et al. · 2024 · Immunity & Ageing
  87. NLRP3 and NLRP1 inflammasomes are up-regulated in patients with mesial temporal lobe epilepsy and may contribute to overexpression of caspase-1 and IL-β in sclerotic hippocampi
    Eliana Cristina de Brito Toscano, Érica Leandro Marciano Vieira, Bárbara Boni Rocha Dias, Marcelo Vidigal Caliari, Ana Paula Gonçalves, Alexandre Varella Giannetti, José Maurício Siqueira, Cláudia Kimie Suemoto, Renata Elaine Paraízo Leite, Ricardo Nitríni et al. · 2020 · Brain Research
  88. Mechanisms of NLRP1-Mediated Autoinflammatory Disease in Humans and Mice
    Chien‐Hsiung Yu, Jonas Moecking, Matthias Geyer, Seth Lucian Masters · 2017 · Journal of Molecular Biology
  89. Neuroinflammatory Responses and Parkinson’ Disease: Pathogenic Mechanisms and Therapeutic Targets
    Liuna Yang, Kanmin Mao, Honglin Yu, Jialong Chen · 2020 · Journal of Neuroimmune Pharmacology
  90. The neuroprotective effects of targeting key factors of neuronal cell death in neurodegenerative diseases: The role of ER stress, oxidative stress, and neuroinflammation
    Mohammad Sobhan Karvandi, Farzam Sheikhzadeh Hesari, Amir Reza Aref, Majid Mahdavi · 2023 · Frontiers in Cellular Neuroscience
  91. Antiferroptotic activity of non-oxidative dopamine
    Ding Wang, Yingpeng Peng, Yangchun Xie, Bo Zhou, Xiaofang Sun, Rui Kang, Daolin Tang · 2016 · Biochemical and Biophysical Research Communications
  92. Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome
    Yoshiyuki Mishima, Shunji Ishihara · 2020 · International Journal of Molecular Sciences
  93. Dynamic Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson’s Disease
    Dongping Huang, Jing Xu, Jinghui Wang, Jiabin Tong, Xiaochen Bai, Heng Li, Zishan Wang, Yulu Huang, Yufei Wu, Mei Yu et al. · 2017 · Parkinson s Disease
  94. Role of NLRP3 Inflammasome in Parkinson’s Disease and Therapeutic Considerations
    Linh Thi Nhat Nguyen, Hữu Đạt Nguyễn, Yun Joong Kim, Tinh Thi Nguyen, Thuy Thi Lai, Yoon Kyoung Lee, Hyeo‐Il Ma, Young Eun Kim · 2022 · Journal of Parkinson s Disease
  95. The Cross-Talk Between the Dopaminergic and the Immune System Involved in Schizophrenia
    Pia Maria Vidal, Rodrigo Pacheco · 2020 · Frontiers in Pharmacology
  96. Celastrol ameliorates Propionibacterium acnes/LPS-induced liver damage and MSU-induced gouty arthritis via inhibiting K63 deubiquitination of NLRP3
    Chang‐Yu Yan, Shu‐Hua Ouyang, Xi Wang, Yanping Wu, Wan‐Yang Sun, Wen‐Jun Duan, Lei Liang, Xiang Luo, Hiroshi Kurihara, Yi-Fang Li et al. · 2020 · Phytomedicine
  97. The modulatory role of dopamine receptors in brain neuroinflammation
    Qing-Peng Xia, Zhao-Yan Cheng, Ling He · 2019 · International Immunopharmacology
  98. Activation and Function of NLRP3 Inflammasome in Bone and Joint-Related Diseases
    Tomohiko Murakami, Yuri Nakaminami, Yoshifumi Takahata, Kenji Hata, Riko Nishimura · 2022 · International Journal of Molecular Sciences
  99. Naringenin Produces Neuroprotection Against LPS-Induced Dopamine Neurotoxicity via the Inhibition of Microglial NLRP3 Inflammasome Activation
    Ce Chen, Yi-Zheng Wei, Xuemei He, Daidi Li, Guoqing Wang, Jing-Jie Li, Feng Zhang · 2019 · Frontiers in Immunology
  100. Dopamine receptor D3 signalling in astrocytes promotes neuroinflammation
    Andro Montoya, Daniela Elgueta, Javier Campos, Ornella Chovar, Paulina Falcón, Soledad Matus, Iván E. Alfaro, Marı́a Rosa Bono, Rodrigo Pacheco · 2019 · Journal of Neuroinflammation